[1] |
Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the diagnosis and treatment of pancreatic cancer in China(2021)[J]. Chin J Dig Surg, 2021, 20(7): 713-729. DOI: 10.3760/cma.j.cn115610-20210618-00289.
中华医学会外科学分会胰腺外科学组. 中国胰腺癌诊治指南(2021)[J]. 中华消化外科杂志, 2021, 20(7): 713-729. DOI: 10.3760/cma.j.cn115610-20210618-00289.
|
[2] |
CAI J, CHEN HD, LU M, et al. Trend analysis on morbidity and mortality of pancreatic cancer in China, 2005-2015[J]. Chin J Epidemiol, 2021, 42(5): 794-800. DOI: 10.3760/cma.j.cn112338-20201115-01328.
蔡洁, 陈宏达, 卢明, 等. 2005-2015年中国胰腺癌发病与死亡趋势分析[J]. 中华流行病学杂志, 2021, 42(5): 794-800. DOI: 10.3760/cma.j.cn112338-20201115-01328.
|
[3] |
YANG H, WANG XK, FAN JH. Present status of epidemiology, risk factors and screening of pancreatic cancer in China[J]. Cancer Res Prev Treat, 2021, 48(10): 909-915. DOI: 10.3971/j.issn.1000-8578.2021.21.0789.
杨欢, 王晓坤, 范金虎. 中国胰腺癌流行病学、危险因素及筛查现况[J]. 肿瘤防治研究, 2021, 48(10): 909-915. DOI: 10.3971/j.issn.1000-8578.2021.21.0789.
|
[4] |
ZHENG LC, LIU GC, OUYANG XL, et al. Diagnosis of 18F-FDG PET/CT imaging in benign and malignant pancreatic lesions[J]. Chin J Med Imaging, 2018, 26(9): 680-684. DOI: 10.3969/j.issn.1005-5185.2018.09.010.
郑立春, 刘桂超, 欧阳向柳, 等. ~(18)F-FDG PET/CT显像对胰腺良恶性病变的诊断价值[J]. 中国医学影像学杂志, 2018, 26(9): 680-684. DOI: 10.3969/j.issn.1005-5185.2018.09.010.
|
[5] |
PU Y, WANG C, ZHAO S, et al. The clinical application of 18F-FDG PET/CT in pancreatic cancer: a narrative review[J]. Transl Cancer Res, 2021, 10(7): 3560-3575. DOI: 10.21037/tcr-21-169.
|
[6] |
GAO B, OUYANG XL, ZHANG HL, et al. Diagnostic value of contrast-enhanced ultrasound in aged patients with pancreatic tumors[J]. Chin J Ultrasound in Med, 2018, 34(8): 706-709. DOI: 10.3969/j.issn.1002-0101.2018.08.010.
高蓓, 欧阳向柳, 张浩良, 等. 超声造影对于老年胰腺肿瘤患者的诊断价值分析[J]. 中国超声医学杂志, 2018, 34(8): 706-709. DOI: 10.3969/j.issn.1002-0101.2018.08.010.
|
[7] |
LI S, JIANG H, WANG Z, et al. An effective computer aided diagnosis model for pancreas cancer on PET/CT images[J]. Comput Methods Programs Biomed, 2018, 165: 205-214. DOI: 10.1016/j.cmpb.2018.09.001.
|
[8] |
MYSSAYEV A, MYSSAYEV A, IDEGUCHI R, et al. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma[J]. PLoS One, 2019, 14(1): e0210178. DOI: 10.1371/journal.pone.0210178.
|
[9] |
YAMASHITA YI, OKABE H, HAYASHI H, et al. Usefulness of 18-FDG PET/CT in detecting malignancy in intraductal papillary mucinous neoplasms of the pancreas[J]. Anticancer Res, 2019, 39(5): 2493-2499. DOI: 10.21873/anticanres.13369.
|
[10] |
REN SN, LI DN, PAN GX, et al. Research progress in diagnosis and prognosis evaluation of pancreatic cancer by~(18)F-FDG PET/CT[J]. Chin J Pancreatol, 2019, 19(4): 307-310. DOI: 10.3760/cma.j.issn.1674-1935.2019.04.018.
任胜男, 李丹妮, 潘桂霞, 等. 胰腺癌~(18)F-FDG PET/CT诊断及预后评估的研究进展[J]. 中华胰腺病杂志, 2019, 19(4): 307-310. DOI: 10.3760/cma.j.issn.1674-1935.2019.04.018.
|
[11] |
SRINIVASAN N, KOH YX, GOH B. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas[J]. Surgery, 2019, 165(5): 929-937. DOI: 10.1016/j.surg.2018.11.006.
|
[12] |
DUNET V, HALKIC N, SEMPOUX C, et al. Use of PET and MRI imaging features to predict grade and survival of resectable pancreatic ductal adenocarcinoma[J]. Inter J Med Rad, 2021, 44(2): 247. DOI: 10.19300/j.2021.e0211.
DUNET V, HALKIC N, SEMPOUX C, 等. 应用PET和MRI影像学特征预测可切除的胰腺导管腺癌肿瘤分级及生存率[J]. 国际医学放射学杂志, 2021, 44(2): 247. DOI: 10.19300/j.2021.e0211.
|
[13] |
WANG PP, HUO L, LIU Y, et al. Clinical value of 18F-FDG PET/CT imaging in non-functional pancreatic neuroendocrine neoplasms[J]. Chin J Nuclear Med Mol Imaging, 2022, 42(3): 139-143. DOI: 10.3760/cma.j.cn321828-20200721-00288.
王佩佩, 霍力, 刘宇, 等. 无功能胰腺神经内分泌肿瘤~(18)F-FDG PET/CT显像的临床应用价值[J]. 中华核医学与分子影像杂志, 2022, 42(3): 139-143. DOI: 10.3760/cma.j.cn321828-20200721-00288.
|
[14] |
YAMANE T, AIKAWA M, YASUDA M, et al. [18F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer[J]. EJNMMI Res, 2019, 9(1): 39. DOI: 10.1186/s13550-019-0507-8.
|
[15] |
LIERMANN J, SYED M, BEN-JOSEF E, et al. Impact of FAPI-PET/CT on target volume definition in radiation therapy of locally recurrent pancreatic cancer[J]. Cancers (Basel), 2021, 13(4). DOI: 10.3390/cancers13040796.
|
[16] |
BONACINA M, GHIRARDELLI P, SETTI L, et al. 68Ga-PSMA and 68Ga-DOTATOC PET/CT imaging mismatch of primary pancreatic adenocarcinoma in prostate cancer patient[J]. Eur J Nucl Med Mol Imaging, 2022, 49(2): 781-782. DOI: 10.1007/s00259-021-05523-9.
|
[17] |
ZHANG Z, JIA G, PAN G, et al. Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer[J]. Eur J Nucl Med Mol Imaging, 2022, 49(8): 2877-2888. DOI: 10.1007/s00259-022-05729-5.
|
[18] |
JIA W, YIN LL, JI B, et al. Comparison of 18F-FDG PET/CT and enhanced CT to assess the tumor stage, vascular invasion, distant metastasis and surgical indications of pancreatic cancer[J]. Chin J Gen Surg, 2019, 28(3): 360-365. DOI: 10.7659/j.issn.1005-6947.2019.03.017.
贾维, 印隆林, 季冰, 等. ~(18)F-FDG PET/CT显像与增强CT评估胰腺癌分期、血管侵犯、远处转移和手术指征的比较[J]. 中国普通外科杂志, 2019, 28(3): 360-365. DOI: 10.7659/j.issn.1005-6947.2019.03.017.
|
[19] |
LIN ZM, PAN MQ, XU YY, et al. Contrast enhanced ultrasonography vs. contrast enhanced computed tomography for the diagnosis of focal lesions of the pancreas[J]. Chin J Gen Surg, 2018, 33(10): 849-852. DOI: 10.3760/cma.j.issn.1007-631X.2018.10.013.
林子梅, 潘敏强, 徐永远, 等. 胰腺实性局灶性病变的超声造影与增强CT对照研究[J]. 中华普通外科杂志, 2018, 33(10): 849-852. DOI: 10.3760/cma.j.issn.1007-631X.2018.10.013.
|
[20] |
LIN ZM, WEN Q, XU YY, et al. Application of contrast enhanced ultrasound in TN staging of pancreas cancer: comparsion with contrast enhanced computed tomography[J]. China J Ultrasonography, 2018, 27(7): 614-617. DOI: 10.3760/cma.j.issn.1004-4477.2018.07.014.
林子梅, 闻卿, 徐永远, 等. 超声造影在胰腺癌T、N分期中的应用价值[J]. 中华超声影像学杂志, 2018, 27(7): 614-617. DOI: 10.3760/cma.j.issn.1004-4477.2018.07.014.
|
[21] |
WU LQ, LIU XH, LUAN ZY, et al. Meta-analysis on the differential diagnosis of benign and malignant pancreatic masses by contrast-enhanced ultrasound[J]. J Clin Ultrasound Med, 2018, 20(6): 383-387. DOI: 10.3969/j.issn.1008-6978.2018.06.009.
吴亮群, 刘雪红, 栾智勇, 等. 超声造影鉴别诊断胰腺良恶性病变的Meta分析[J]. 临床超声医学杂志, 2018, 20(6): 383-387. DOI: 10.3969/j.issn.1008-6978.2018.06.009.
|
[22] |
LI Y, XU Y, SONG YF, et al. Clinical value of contrast-enhanced ultrasound in differentiating focal pancreatitis from pancreatic cancer: a comparative study with conventional ultrasound[J]. J Chin Med Imaging, 2021, 32(10): 729-732. DOI: 10.12117/jccmi.2021.10.011.
李煜, 许芸, 宋一凡. 超声造影增强模式鉴别局灶性胰腺炎与胰腺癌的临床价值: 与常规超声的对照研究[J]. 中国临床医学影像杂志, 2021, 32(10): 729-732. DOI: 10.12117/jccmi.2021.10.011.
|
[23] |
XU J, CHEN YL, WANG XW. Comparison on Clinical Value of 18F-FDG PET/CT, Enhanced CT, and MRI in Differential Diagnosis of Benign and Malignant Pancreas Cystic Lesions[J]. Chin J CT and MRI, 2022, 20(2): 99-101. DOI: 10.3969/j.issn.1672-5131.2022.02.033.
徐杰, 陈艳林, 王雪伟. ~(18)F-FDG PET/CT与增强CT、MRI在诊断鉴别胰腺囊性良恶性病变的临床价值比较[J]. 中国CT和MRI杂志, 2022, 20(2): 99-101. DOI: 10.3969/j.issn.1672-5131.2022.02.033.
|